| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/23/2006 | US20060063167 DNA and proteins or peptides specific of the Neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 03/23/2006 | US20060063158 Analyzing preferential nucleotide sequence; obtain nucleotide sequences, fragment, incubate with adaptor sequences, ligate, denature sequences, incubate with primer and amplify sequences, evaluate hybridizaton pattern; detecting a single nucleotide polymorphism (SNP) allele in in a genomic DNA |
| 03/23/2006 | US20060063156 Outcome prediction and risk classification in childhood leukemia |
| 03/23/2006 | US20060063153 Interaction detecting method and bioassay device, and bioassay-use substrate |
| 03/23/2006 | US20060063152 Novel gene and protein encoded by the gene |
| 03/23/2006 | US20060063150 Antisense antiviral compound and method for treating ssRNA viral infection |
| 03/23/2006 | US20060063149 Compositions and methods for detecting pathogen infection |
| 03/23/2006 | US20060062855 Therapeutic calcium phosphate particles for use in inhibiting expression of a gene |
| 03/23/2006 | US20060062841 Liposomal vectors |
| 03/23/2006 | US20060062805 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
| 03/23/2006 | US20060062804 High sensitivity and specificity of the serologic detection; rapid, simple, low cost test for commercially available, large scale screening of SARS patients |
| 03/23/2006 | US20060062803 a nucleic acid fhaving a first nucleotide sequence encoding nonstructural proteins from attenuated dengue-2 virus vaccine strain PDK-53, and a second nucleotide sequence encoding a structural protein from a second flavivirus; amino acid mutations in the nontstructural proteins; vaccines |
| 03/23/2006 | US20060062800 Immunogens; envelope proteins; kits |
| 03/23/2006 | US20060062799 Sperm specific lysozyme-like proteins |
| 03/23/2006 | US20060062798 Vaccines |
| 03/23/2006 | US20060062795 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 03/23/2006 | US20060062792 Novel human p53 splice variant displaying differential transcriptional activity |
| 03/23/2006 | US20060062790 AKT3 inhibitors |
| 03/23/2006 | US20060062789 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia |
| 03/23/2006 | US20060062788 Method for determining MIF content |
| 03/23/2006 | US20060062782 Anti-IgE vaccines |
| 03/23/2006 | US20060062775 Method for the production of protamine |
| 03/23/2006 | US20060062772 Polypeptide delivery system |
| 03/23/2006 | US20060062769 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine |
| 03/23/2006 | US20060062765 Lentiviral vector-mediated gene transfer and uses thereof |
| 03/23/2006 | US20060062764 Fiber-modified adenoviral vectors for enhanced transduction of tumor cells |
| 03/23/2006 | US20060062761 Modified interferon alpha with reduced immunogenicity |
| 03/23/2006 | US20060062730 Increasing transdermal absorption by mixing isostearyl alcohol with a substance such as hair growing agent, a gray-hair prevention agent, a hair-removing agent, a hair-dyeing agent, or a hair-bleaching agent; pantothenyl ethyl ether, minoxidil, or beta-glycyrrhetinic acid |
| 03/23/2006 | US20060062074 Method for intracellular modifications within living cells using pulsed electric fields |
| 03/23/2006 | US20060060211 Modifying nicotine and nitrosamine levels in tobacco |
| 03/23/2006 | DE102005002530A1 Chimäre DNA-Polymerase Chimeric DNA polymerase |
| 03/23/2006 | DE102004043629A1 New communication-mediating domains of biosynthesis complexes, useful for preparation of modified forms of non-ribosomal peptides or their polyketide complexes, potential therapeutic agents |
| 03/23/2006 | DE102004043207A1 Wurzel- und xylemparenchymspezifischer Promotor Root and xylemparenchymspezifischer promoter |
| 03/23/2006 | DE102004036466A1 Verfahren zur Herstellung von C6- und/oder C9-Aldehyden und -Alkoholen in Pflanzen durch 9/13-Divinylethersynthase Process for the preparation of C6 and / or C9-aldehydes and alcohols in plants by 9/13-Divinylethersynthase |
| 03/23/2006 | DE102004036456A1 Verfahren zur Herstellung von transgenen Pflanzen mit erhöhter Pathogenresistenz durch Veränderung des Gehalts und/oder der Aktivität von Actin-depolymerisierenden Faktoren A process for the production of transgenic plants with increased pathogen resistance by varying the content and / or activity of actin depolymerizing factors |
| 03/23/2006 | DE10162176B4 Verfahren zum simultanen positionsspezifischen Schneiden von DNA A method for simultaneous cutting of position-specific DNA |
| 03/23/2006 | CA2823429A1 Sialidase catalytic domain proteins |
| 03/23/2006 | CA2583199A1 The use of an inhibitor of heterotetrameric annexin 2 for treating viral infections |
| 03/23/2006 | CA2580713A1 Isolated polypeptides and polynucleotides encoding same for generating plants with increased cuticlar water permeability |
| 03/23/2006 | CA2580560A1 Compositions and methods for inhibiting expression of anti-apoptotic genes |
| 03/23/2006 | CA2580537A1 Compositions and their uses for lysosomal enzyme deficiencies |
| 03/23/2006 | CA2580416A1 Method for estimating end use qualities of wheat at growth stage |
| 03/23/2006 | CA2580412A1 Compositions comprising t cell receptors and methods of use thereof |
| 03/23/2006 | CA2580260A1 Modulating plant sugar levels |
| 03/23/2006 | CA2580201A1 Promoter molecules for use in plants |
| 03/23/2006 | CA2580061A1 Promoters for regulating gene expression in plant seeds |
| 03/23/2006 | CA2580044A1 Gene identification signature (gis) analysis for transcript mapping |
| 03/23/2006 | CA2580011A1 Method of accelerating somatic mutations and use thereof in proteomics |
| 03/23/2006 | CA2580010A1 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response |
| 03/23/2006 | CA2580009A1 Host-vector system for antibiotic-free cole1 plasmid propagation |
| 03/23/2006 | CA2579789A1 Overexpressed and purified aspergillus ficuum oxidase and nucleic acid encoding the same |
| 03/23/2006 | CA2579368A1 Sialyltransferases comprising conserved sequence motifs |
| 03/23/2006 | CA2579340A1 Stable liquid formulations of plasmid dna |
| 03/23/2006 | CA2578050A1 Sialidase catalytic domain proteins |
| 03/23/2006 | CA2576055A1 Methods and compositions for cell activation |
| 03/22/2006 | EP1637881A1 Sample arraying/assembling device, its method, and apparatus using sample assembly |
| 03/22/2006 | EP1637872A1 Bioassay substrate and bioassay device and method |
| 03/22/2006 | EP1637867A1 Molecule detecting method, molecule counting method, molecule localization detecting method, molecule detection device used for them |
| 03/22/2006 | EP1637614A2 Nucleic acids and antibodies for detection of ISAV (infectious salmon anaemia virus) |
| 03/22/2006 | EP1637611A1 Method for producing oligosaccharides |
| 03/22/2006 | EP1637608A2 Recombinant adenoviral vector and methods of use |
| 03/22/2006 | EP1637607A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
| 03/22/2006 | EP1637606A2 Triacylglycerol lipases |
| 03/22/2006 | EP1637604A2 Method for producing proteins |
| 03/22/2006 | EP1637603A1 Dna coding for protein having d-lactic acid dehydrogenase activity and use thereof |
| 03/22/2006 | EP1637602A1 Recombinant method for preparing of a complete malaria antigen gp190/msp1 |
| 03/22/2006 | EP1637601A2 Proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2006 | EP1637600A1 Chromosome 1 gene and gene products related to Alzheimer's disease |
| 03/22/2006 | EP1637599A2 Method of nucleic acid isolation |
| 03/22/2006 | EP1637598A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 03/22/2006 | EP1637597A1 Method of nucleic acid infusion |
| 03/22/2006 | EP1637596A1 Alkaline bacillus amylase |
| 03/22/2006 | EP1637595A1 Overexpressed and purified Aspergillus ficuum oxidase and nucleic acid encoding same |
| 03/22/2006 | EP1637592A1 Neuronal progenitor cells, methods to produce them and uses thereof for the therapy of neural defects |
| 03/22/2006 | EP1637591A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoc |
| 03/22/2006 | EP1637540A1 Hyperactive Stat molecules and their use in assays employing gene activation |
| 03/22/2006 | EP1637173A2 Particle delivery |
| 03/22/2006 | EP1637144A1 Oligonucleic acid-bearing composite and pharmaceutical composition containing the composite |
| 03/22/2006 | EP1636845A2 Wet chemical processing chambers for processing microfeature workpieces |
| 03/22/2006 | EP1636561A2 Combinatorial protein library screening by periplasmic expression |
| 03/22/2006 | EP1636389A1 Plasmid-free clone of e. coli strain dsm 6601 |
| 03/22/2006 | EP1636385A2 Inhibition of gene function by delivery of polynucleotide-based gene expression inhibitors to mammalian cells in vivo |
| 03/22/2006 | EP1636384A2 Gene amplification and overexpression in cancer |
| 03/22/2006 | EP1636383A1 Composition for screening anti-hypertension drug comprising mammal tctp gene or its protein product, and method for screening anti-hypertension drug using said composition |
| 03/22/2006 | EP1636377A2 Genotype test for dogs |
| 03/22/2006 | EP1636371A1 Negative strand rna virus replicon |
| 03/22/2006 | EP1636370A2 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 03/22/2006 | EP1636369A1 Limit dextrinase inhibitor promoter |
| 03/22/2006 | EP1636368A2 Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase promoters for gene expression in oleaginous yeast |
| 03/22/2006 | EP1636367A2 Method for producing a recombinant protein of interest and protein thus produced |
| 03/22/2006 | EP1636366A1 Feedback resistant acetohydroxy acid synthethase mutants |
| 03/22/2006 | EP1636365A1 Cholesterol biosynthesis pathway modulators and uses thereof |
| 03/22/2006 | EP1636364A2 INHIBITION OF APOPTOSIS-SPECIFIC ELF-5A ( EIF-5A1) WITH ANTISENSE OLIGONUCLEOTIDES AND siRNAs AS ANTI-INFLAMMATORY THERAPEUTICS |
| 03/22/2006 | EP1636363A1 Antisense oligonucleotides directed to ribonucleotide reductase r1 and uses thereof in the treatment of cancer |
| 03/22/2006 | EP1636362A2 Disease related protein network |
| 03/22/2006 | EP1636361A1 Method for the isolation of expressed sequence tags in plants |
| 03/22/2006 | EP1636360A1 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 03/22/2006 | EP1636359A2 Methods for treating pain |
| 03/22/2006 | EP1636356A1 Novel modified corin molecules having substitute activation sequences and uses thereof |
| 03/22/2006 | EP1636354A2 Erk7 and erk8, novel diagnostic markers for cancer |